North Capital’s GE HealthCare GEHC Stock Holding History

North Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-38	Closed	-$2.86K	–	336
2025 Q3	$2.86K	Sell	38 -16	-30%	-$1.19K	﹤0.01%	489
2025 Q2	$4K	Hold	54	–	–	﹤0.01%	462
2025 Q1	$4.36K	Buy	+54	New	+$4.64K	﹤0.01%	443

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

North Capital's GEHC Position: Q4 2025 in Review

North Capital sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 38 shares — an estimated $2.86K sold.

North Capital first reported a position in GEHC in Q1 2025 and held it in 3 quarters. The position peaked at $4.36K in Q1 2025. 1,337 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

North Capital reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
North Capital sold 38 GE HealthCare shares in Q4 2025, an estimated $2.86K.
North Capital first reported a position in GE HealthCare in Q1 2025 and held it in 3 quarters.
North Capital's GE HealthCare position peaked at $4.36K in Q1 2025.
1,337 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.